Sasibhushan Vedula

Saroglitazar and Hepano treatment offers protection against high fat high fructose diet induced obesity, insulin resistance and steatosis by modulating various class of hepatic and circulating lipids

Soumalya Sarkar, Deepika Kumari, Sonu Gupta et al. · Biomedicine & Pharmacotherapy · 2021 · 27 citations · Full text

Medicine, Endocrinology, Pharmacology +14

Prospective, Randomized, Open-Label, Blinded End Point, Two-Arm, Comparative Clinical Study to Evaluate the Efficacy and Safety of a Fixed Ayurvedic Regimen (FAR) as Add-on to Conventional Treatment in the Management of Mild and Moderate COVID-19 Patients

Arun Gupta, Sasibhushan Vedula, Ruchi Srivastava et al. · Journal of Pharmacy And Bioallied Sciences · 2021 · 13 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +7

Clinical evaluation of Chyawanprash as a preventive measure during the COVID-19 pandemic: An open-label, multicentric, randomized, comparative, prospective, and interventional community-based clinical study on healthy individuals

Pawan Kumar Godatwar, Shailesh Deshpande, Pranita S. JoshiDeshmukh et al. · Journal of Indian System of Medicine · 2021 · 12 citations

Medicine, Infectious Diseases, Preventive Medicine +13